ОТДАЛЁННЫЕ РЕЗУЛЬТАТЫ РАДИОЧАСТОТНОЙ АБЛАЦИИ ЛЁГОЧНЫХ ВЕН И ИМПЛАНТАЦИИ ФИЗИОЛОГИЧЕСКОЙ СИСТЕМЫ ЭЛЕКТРОКАРДИОСТИМУЛЯЦИИ У ПАЦИЕНТОВ С СИНДРОМОМ ТАХИКАРДИИ-БРАДИКАРДИИ
Аннотация
Об авторах
А. Ш. РевишвилиРоссия
М. Р. Дишеков
Россия
Ж. Х. Темботова
Россия
Список литературы
1. Ревишвили А.Ш., Рзаев Ф.Г., Дишеков М.Р., Темботова Ж.Х. Тезис: отдалённые результаты лечения больных с синдромом тахи-брадикардии // Бюллетень НЦ ССХ им. А.Н. Бакулева РАМН Сердечно-сосудистые заболевания, стр. 94.
2. Rucinski P., Rubaj A., Kutarski A. Pharmacotherapy changes following pacemaker implantation in patients with bradycardia-tachycardia syndrome // Expert opinion on pharmacotherapy. 2006 Nov; 7 (16): 2203-13
3. The CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trials of arrhythmia suppression after myocardial infarction // New Engl. J. Med., 1989; 321: 406-412.
4. Roy D., Talajic M., Dorian P. et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators // N Engl J Med 2000; 342: 913-20.
5. AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation // JACC, 2003; 42: 20-29.
6. Vasamreddy C.R., Dalal D., Dong J. et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation // J Cardiovasc Electrophysiol 2006; 17: 134-139.
7. Hindricks G., Piorkowski C., Tanner H. et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence // Circulation 2005; 112: 307-313.
8. Purerfellner H., Aichinger J., Martinek M. et al. Quantification of atrial tachyarrhythmia burden with an implantable pacemaker before and after pulmonary vein isolation // Pacing Clin Electrophysiol 2004; 27: 1-7.
9. Hsieh M., Tai C., Tsai C. et al. Clinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation // J Cardiovasc Electrophysiol 2003; 14: 598-601.
10. Pappone C., Augello G., Sala S. et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation // J Am Coll Cardiol 2006; 48: 2340-2347.
11. Oral H., Chugh A., Good E. et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation: The APAF study // Circulation 2006; 113: 1824-1831.
12. Haïssaguerre M., Hocini M., Sanders P. et al. Catheter ablation of long-lasting persistent atrial fibrillation: Clinical outcome and mechanisms of subsequent arrhythmias // J Cardiovasc Electrophysiol 2005; 16: 1138-1147.
13. Oral H., Pappone C., Chugh A. et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation // N Engl J Med 2006; 354: 934-941.
14. Hocini M., Jaïs P., Sanders P. et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: A prospective randomized study // Circulation 2005; 112: 3688-3696.
15. Hart R.G., Pearce L.A., Rothbart R.M. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy // J Am Coll Cardiol 2000; 35: 183-187.
16. Wyse D.G., Waldo A.L., DiMarco J.P. et al. A comparison of rate control and rhythm control in patients with atrial fibrillation // N Engl J Med 2002; 347: 1825-1833.
17. Piorkowski C., Kottkamp H., Tanner H. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fi brillation // J Cardiovasc Electrophysiol 2005; 16: 1286-1292. 18. Kottkamp H., Tanner H., Kozba R. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: Trigger elimination or substrate modification: Early or delayed cure? // J Am Coll Cardiol 2004; 44: 869-877.
18. Kottkamp H., Tanner H., Kozba R. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: Trigger elimination or substrate modification: Early or delayed cure? // J Am Coll Cardiol 2004; 44: 869-877
Рецензия
Для цитирования:
Ревишвили А.Ш., Дишеков М.Р., Темботова Ж.Х. ОТДАЛЁННЫЕ РЕЗУЛЬТАТЫ РАДИОЧАСТОТНОЙ АБЛАЦИИ ЛЁГОЧНЫХ ВЕН И ИМПЛАНТАЦИИ ФИЗИОЛОГИЧЕСКОЙ СИСТЕМЫ ЭЛЕКТРОКАРДИОСТИМУЛЯЦИИ У ПАЦИЕНТОВ С СИНДРОМОМ ТАХИКАРДИИ-БРАДИКАРДИИ. Вестник аритмологии. 2009;(57):41-46.
For citation:
Revishvili A.Sh., Dishekov M.R., Tembotova Zh.Kh. LONG-TERM OUTCOMES OF RADIOFREQUENCY ABLATION OF PULMONARY VEINS AND IMPLANTATION OF PHYSIOLOGICAL CARDIAC PACING SYSTEM IN PATIENTS WITH THE TACHYCARDIA-BRADYCARDIA SYNDROME. Journal of Arrhythmology. 2009;(57):41-46. (In Russ.)